David S Knopman1, Alexa Beiser2, Mary M Machulda2, Julie Fields2, Rosebud O Roberts2, V Shane Pankratz2, Jeremiah Aakre2, Ruth H Cha2, Walter A Rocca2, Michelle M Mielke2, Bradley F Boeve2, Sherral Devine2, Robert J Ivnik2, Rhoda Au2, Sanford Auerbach2, Philip A Wolf2, Sudha Seshadri2, Ronald C Petersen2. 1. From the Department of Neurology, Mayo Alzheimer's Disease Research Center (D.S.K., B.F.B., R.C.P., R.O.R., W.A.R.), Division of Epidemiology, Department of Health Sciences Research (R.O.R., M.M. Mielke, W.A.R., R.C.P.), Division of Biostatistics and Bioinformatics, Department of Health Sciences Research (V.S.P., J.A., R.H.C.), and Department of Psychiatry and Psychology, Division of Neurocognitive Disorders (R.J.I., M.M. Machulda, J.F.), College of Medicine, Mayo Clinic, Rochester, MN; and Departments of Neurology (A.B., S.D., R.A., S.A., P.A.W., S.S.) and Biostatistics (A.B.), Boston University Schools of Medicine and Public Health, MA. knopman@mayo.edu. 2. From the Department of Neurology, Mayo Alzheimer's Disease Research Center (D.S.K., B.F.B., R.C.P., R.O.R., W.A.R.), Division of Epidemiology, Department of Health Sciences Research (R.O.R., M.M. Mielke, W.A.R., R.C.P.), Division of Biostatistics and Bioinformatics, Department of Health Sciences Research (V.S.P., J.A., R.H.C.), and Department of Psychiatry and Psychology, Division of Neurocognitive Disorders (R.J.I., M.M. Machulda, J.F.), College of Medicine, Mayo Clinic, Rochester, MN; and Departments of Neurology (A.B., S.D., R.A., S.A., P.A.W., S.S.) and Biostatistics (A.B.), Boston University Schools of Medicine and Public Health, MA.
Abstract
OBJECTIVE: To understand the neuropsychological basis of dementia risk among persons in the spectrum including cognitive normality and mild cognitive impairment. METHODS: We quantitated risk of progression to dementia in elderly persons without dementia from 2 population-based studies, the Framingham Heart Study (FHS) and Mayo Clinic Study of Aging (MCSA), aged 70 to 89 years at enrollment. Baseline cognitive status was defined by performance in 4 domains derived from batteries of neuropsychological tests (that were similar but not identical for FHS and MCSA) at cut scores corresponding to SDs of ≤-0.5, -1, -1.5, and -2 from normative means. Participants were characterized as having no cognitive impairment (reference group), or single or multiple amnestic or nonamnestic profiles at each cut score. Incident dementia over the following 6 years was determined by consensus committee at each study separately. RESULTS: The pattern of hazard ratios for incident dementia, rates of incident dementia and positive predictive values across cognitive test cut scores, and number of affected domains was similar although not identical across the FHS and MCSA. Dementia risks were higher for amnestic profiles than for nonamnestic profiles, and for multidomain compared with single-domain profiles. CONCLUSIONS: Cognitive domain subtypes, defined by neuropsychologically derived cut scores and number of low-performing domains, differ substantially in prognosis in a conceptually logical manner that was consistent between FHS and MCSA. Neuropsychological characterization of elderly persons without dementia provides valuable information about prognosis. The heterogeneity of risk of dementia cannot be captured concisely with one test or a single definition or cutpoint.
OBJECTIVE: To understand the neuropsychological basis of dementia risk among persons in the spectrum including cognitive normality and mild cognitive impairment. METHODS: We quantitated risk of progression to dementia in elderly persons without dementia from 2 population-based studies, the Framingham Heart Study (FHS) and Mayo Clinic Study of Aging (MCSA), aged 70 to 89 years at enrollment. Baseline cognitive status was defined by performance in 4 domains derived from batteries of neuropsychological tests (that were similar but not identical for FHS and MCSA) at cut scores corresponding to SDs of ≤-0.5, -1, -1.5, and -2 from normative means. Participants were characterized as having no cognitive impairment (reference group), or single or multiple amnestic or nonamnestic profiles at each cut score. Incident dementia over the following 6 years was determined by consensus committee at each study separately. RESULTS: The pattern of hazard ratios for incident dementia, rates of incident dementia and positive predictive values across cognitive test cut scores, and number of affected domains was similar although not identical across the FHS and MCSA. Dementia risks were higher for amnestic profiles than for nonamnestic profiles, and for multidomain compared with single-domain profiles. CONCLUSIONS: Cognitive domain subtypes, defined by neuropsychologically derived cut scores and number of low-performing domains, differ substantially in prognosis in a conceptually logical manner that was consistent between FHS and MCSA. Neuropsychological characterization of elderly persons without dementia provides valuable information about prognosis. The heterogeneity of risk of dementia cannot be captured concisely with one test or a single definition or cutpoint.
Authors: P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl Journal: Neurology Date: 2007-01-23 Impact factor: 9.910
Authors: D L Bachman; P A Wolf; R T Linn; J E Knoefel; J L Cobb; A J Belanger; L R White; R B D'Agostino Journal: Neurology Date: 1993-03 Impact factor: 9.910
Authors: S Larrieu; L Letenneur; J M Orgogozo; C Fabrigoule; H Amieva; N Le Carret; P Barberger-Gateau; J F Dartigues Journal: Neurology Date: 2002-11-26 Impact factor: 9.910
Authors: V Solfrizzi; F Panza; A M Colacicco; A D'Introno; C Capurso; F Torres; F Grigoletto; S Maggi; A Del Parigi; E M Reiman; R J Caselli; E Scafato; G Farchi; A Capurso Journal: Neurology Date: 2004-11-23 Impact factor: 9.910
Authors: B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen Journal: J Intern Med Date: 2004-09 Impact factor: 8.989
Authors: Rhoda Au; Sudha Seshadri; Philip A Wolf; Merrill Elias; Penelope Elias; Lisa Sullivan; Alexa Beiser; Ralph B D'Agostino Journal: Exp Aging Res Date: 2004 Oct-Dec Impact factor: 1.645
Authors: Phillip J Schulte; David O Warner; David P Martin; Atousa Deljou; Michelle M Mielke; David S Knopman; Ronald C Petersen; Toby N Weingarten; Matthew A Warner; Alejandro A Rabinstein; Andrew C Hanson; Darrell R Schroeder; Juraj Sprung Journal: Crit Care Med Date: 2019-08 Impact factor: 7.598
Authors: Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen Journal: Alzheimers Dement Date: 2019-05-23 Impact factor: 21.566
Authors: David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Bradley F Boeve; David T Jones; Jon Graff-Radford; Sabrina M Albertson; Christopher G Schwarz; Ronald C Petersen; Clifford R Jack Journal: Brain Date: 2019-04-01 Impact factor: 13.501
Authors: Clifford R Jack; Heather J Wiste; Terry M Therneau; Stephen D Weigand; David S Knopman; Michelle M Mielke; Val J Lowe; Prashanthi Vemuri; Mary M Machulda; Christopher G Schwarz; Jeffrey L Gunter; Matthew L Senjem; Jonathan Graff-Radford; David T Jones; Rosebud O Roberts; Walter A Rocca; Ronald C Petersen Journal: JAMA Date: 2019-06-18 Impact factor: 56.272
Authors: P J Schulte; R O Roberts; D S Knopman; R C Petersen; A C Hanson; D R Schroeder; T N Weingarten; D P Martin; D O Warner; J Sprung Journal: Br J Anaesth Date: 2018-06-27 Impact factor: 9.166
Authors: Brianne M Bettcher; Alden L Gross; Brandon E Gavett; Keith F Widaman; Evan Fletcher; N Maritza Dowling; Rachel F Buckley; Eider M Arenaza-Urquijo; Laura B Zahodne; Timothy J Hohman; Jet M J Vonk; Dorene M Rentz; Dan Mungas Journal: Neurobiol Aging Date: 2019-08-21 Impact factor: 4.673
Authors: Nikki H Stricker; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Shehroo B Pudumjee; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Rosebud O Roberts; Bradley F Boeve; David T Jones; Ronald C Petersen; Clifford R Jack Journal: Neurobiol Aging Date: 2018-02-02 Impact factor: 4.673